Uranium-chelating peptides and uses thereof
US-9321849-B2 · Apr 26, 2016 · US
US9845343B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9845343-B2 |
| Application number | US-201414779114-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 28, 2014 |
| Priority date | Mar 28, 2013 |
| Publication date | Dec 19, 2017 |
| Grant date | Dec 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Uranium-chelating polypeptides comprising at least one helix-loop-helix calcium-binding (EF-hand) motif which comprises a deletion of at least two amino acid in the 12-amino-acid calcium-binding loop sequence, and their use for uranium biodetection and biodecontamination.
Opening claim text (preview).
The invention claimed is: 1. A polypeptide comprising at least one helix-loop-helix calcium-binding (EF-hand) motif with deletion of two amino acid residues in the 12-amino-acid calcium-binding loop sequence selected from the group consisting of deletion in positions 1 and 2, and deletion in positions 2 and 3, wherein said polypeptide binds uranyl. 2. The polypeptide of claim 1 , wherein said EF-hand motif(s) are derived from signaling EF-hand protein(s) of the calmodulin superfamily selected from the group consisting of calmodulin and troponin C. 3. The polypeptide of claim 1 , which comprises two or four EF-hand motifs, wherein at least one EF-hand motif comprises said deletion in the calcium-binding loop sequence, and the other EF-hand motif(s) comprise said deletion or not. 4. The polypeptide of claim 2 , which is a calmodulin domain 1 variant comprising two EF-hand motifs, respectively from the EF-hand 1 and the EF-hand2 of calmodulin protein(s). 5. The polypeptide of claim 3 , which comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 17, 18, 20 and 60. 6. A fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety. 7. The fusion protein of claim 6 , which is a cameleon protein comprising tandem fusions of a fluorescence-donor protein, a polypeptide which comprises two or four EF-hand motifs, wherein at least one EF-hand motif comprises said deletion in the calcium-binding loop sequence and the other EF-hand motif(s) comprise said deletion or not, and a fluorescence-acceptor protein. 8. The fusion protein of claim 7 , which comprises a sequence selected from the group consisting of SEQ ID NO: 35, 38, 61, 63 and 67. 9. The polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, which is immobilized onto a solid support. 10. A polynucleotide encoding the polypeptide of claim 1 . 11. A host cell comprising with the polynucleotide of claim 10 , wherein the host cell is not an organism. 12. A non-human transgenic organism comprising the polynucleotide of claim 10 . 13. A method of detecting uranium contamination in a sample comprising contacting the sample with a uranyl chelating agent comprising: i. the polypeptide of claim 1 , ii. a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, iii. a host cell comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, or iv. A non-human transgenic organism comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, and detecting the presence of uranyl chelation in the sample. 14. A method of decontaminating or bio-remediating a sample containing uranium comprising contacting the sample with a uranyl chelating agent comprising: i. the polypeptide of claim 1 , ii. a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, iii. a host cell comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, or iv. A non-human transgenic organism comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety. 15. The polypeptide of claim 3 , which consists of an amino acid sequence selected from the group consisting of SEQ ID NO: 17, 18, 20 and 60. 16. The fusion protein of claim 7 , which consists of a sequence selected from the group consisting of SEQ ID NO: 35, 38, 61, 63 and 67. 17. A polynucleotide encoding a fusion protein comprising the polypeptide according to claim 1 fused to another protein moiety.
Calcium binding proteins, e.g. calmodulin · CPC title
in polymeric matrix, e.g. resins, tars · CPC title
containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title
Metals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.